In a preclinical study, a new CAR T-cell strategy was very successful against small cell lung cancer.

Published Date: 26 Apr 2023

In a preclinical study, a novel method of CAR T-cell therapy against small cell lung cancer (SCLC) has shown great promise. Our knowledge of CAR T has been expanded by the findings.

Read Full News

Latest News

Combination immunotherapy for rare cancers shows improved efficacy and survival rates

New results from a multicenter clinical trial show that combining immunotherapy drugs nivolumab and ipilimumab significantly improves treatment response in patients with advanced and difficult-to-treat cancers. The trial ...

Shaping immunity: The secrets behind the shape of neutrophils

Researchers at the Kennedy Institute have provided the most comprehensive overview to date of how the distinctive segmented nucleus of neutrophils influences their function in health and disease.

Surgery after immunotherapy boosts survival for liver cancer patients

A new Cedars-Sinai Cancer study shows that patients with advanced liver cancer who receive immunotherapy to shrink their tumors have improved outcomes after liver transplant or tumor removal.

How controlling sunburn-triggered inflammation may prevent skin cancer

Sunlight is vital for human health as it helps the body produce essential nutrients, such as vitamin D. However, too much sun exposure can significantly increase the risk of skin cancer.

Icotrokinra beneficial for adults, teens with plaque psoriasis

For adults and adolescents with moderate-to-severe plaque psoriasis, selective blockade of the interleukin-23 receptor with the targeted oral peptide icotrokinra yields a significantly higher incidence of skin clearance at ...

Common cold virus may unlock better COVID vaccine

Prior exposure to coronaviruses that cause ordinary colds can boost the immune system's ability to attack a vulnerable site on the COVID-19-causing coronavirus SARS-CoV-2, according to a study led by investigators at Weill ...

Todays Updates

Why palliative care goes hand in hand with treatment for people with cancer: Q&A

For many people with cancer and other serious diseases, palliative care is an important element of their journey.

Single-dose radiation before surgery can eradicate breast cancer

A single, targeted high dose of radiation delivered before other treatments could completely eradicate tumors in most women with early-stage, operable hormone-positive breast cancer, according to a study led by UT Southwestern ...

Todays Updates

Why palliative care goes hand in hand with treatment for people with cancer: Q&A

For many people with cancer and other serious diseases, palliative care is an important element of their journey.

Single-dose radiation before surgery can eradicate breast cancer

A single, targeted high dose of radiation delivered before other treatments could completely eradicate tumors in most women with early-stage, operable hormone-positive breast cancer, according to a study led by UT Southwestern ...

Latest News

New results from a multicenter clinical trial show that combining immunotherapy drugs nivolumab and ipilimumab significantly improves treatment response in patients with advanced and difficult-to-treat cancers. The trial ...

Researchers at the Kennedy Institute have provided the most comprehensive overview to date of how the distinctive segmented nucleus of neutrophils influences their function in health and disease.

A new Cedars-Sinai Cancer study shows that patients with advanced liver cancer who receive immunotherapy to shrink their tumors have improved outcomes after liver transplant or tumor removal.

Sunlight is vital for human health as it helps the body produce essential nutrients, such as vitamin D. However, too much sun exposure can significantly increase the risk of skin cancer.

For adults and adolescents with moderate-to-severe plaque psoriasis, selective blockade of the interleukin-23 receptor with the targeted oral peptide icotrokinra yields a significantly higher incidence of skin clearance at ...

Prior exposure to coronaviruses that cause ordinary colds can boost the immune system's ability to attack a vulnerable site on the COVID-19-causing coronavirus SARS-CoV-2, according to a study led by investigators at Weill ...

News All Time

Flu vaccine performance varies by age, study reveals

New research comparing four different flu vaccines found that the ability of the vaccines to activate cells of the immune system that help to protect against infection varied greatly depending on the vaccine type and age ...

Newly identified lymphoma subtype gives hope in fight against aggressive form of blood cancer

Researchers at the University of Southampton have identified a new subtype of lymphoma that could pave the way to improved and more targeted treatments for some blood cancer patients. The cancer scientists and biologists ...

Blood test offers hope for more effective ovarian cancer treatment

New clinical research has identified a blood test that can reveal which women are more likely to respond to a particular treatment for ovarian cancer, known as PARP inhibitor therapy.

Q&A: Connection between a distinct immune cell and colitis discovered

CU Anschutz researchers uncovered a link between a type of mucosal immune cell and gut inflammation, finding that the cells exacerbate inflammation and lead to chronic disease in certain conditions.

FDA grants fast track designation to drug combo for colorectal cancer

The U.S. Food and Drug Administration has granted Fast Track Designation to a new drug combination for metastatic colorectal cancer, following encouraging results from a clinical trial led in part by the University of Oklahoma ...

T cell therapies show long-term HPV gains

Researchers from Rutgers Cancer Institute, New Jersey's only National Cancer Institute (NCI)—designated Comprehensive Cancer Center, and RWJBarnabas Health, along with colleagues from the National Cancer Institute, a center ...

Sleep issues linked to higher risk of severe asthma in children

About 30 to 40% of children with asthma experience sleep difficulties due to symptoms like coughing and wheezing. Poor sleep increases the risk of severe asthma exacerbations (attacks) that often necessitate a hospitalization ...

Unique immune signatures can distinguish rare autoimmune condition from multiple sclerosis

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a rare autoimmune condition in which the body's immune system mistakenly attacks the protective myelin sheath of nerve fibers in the central nervous ...

What is myasthenia gravis, the rare disease tennis great Monica Seles lives with?

Former tennis star Monica Seles recently revealed she is living with the rare disease myasthenia gravis, which affects 12 in 100,000 people globally.

Largest study on infant-type hemispheric glioma reports factors to guide treatment approaches

Clinician-scientists at St. Jude Children's Research Hospital and collaborators have conducted the largest study of infant-type hemispheric glioma (IHG) ever reported, uncovering key factors that could be used to guide treatment ...

Factoring in frailty and age could improve pancreatic cancer treatment

While some risk factors for cancer can be mitigated through lifestyle choices such as diet or exercise, aging is not one of them. In the case of pancreatic cancer, it also can limit treatment options if a patient is too frail ...

HER2-targeted radioimmunotherapy regimen achieves complete and durable response in breast cancer model

A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 (HER2)-positive breast cancer, according to new research published in the November issue of The Journal of Nuclear Medicine. ...

Combination immunotherapy helps overcome melanoma treatment resistance

Early data from a Phase 2 clinical trial show a combination of immunotherapy medications can activate a robust immune response and help overcome treatment resistance in patients with refractory melanoma.

Promising drug can inhibit aggressive breast cancer

New research reveals a drug developed by scientists at Oregon Health & Science University may develop into a new treatment for an especially aggressive form of breast cancer.

How colorectal cancer evades immunotherapy using a dual barrier

Colorectal cancer is one of the leading causes of cancer death worldwide. In recent years, immunotherapies—treatments that reactivate the immune system to attack tumor cells—have transformed the treatment of many types ...

A toast to BRD4: How acidity changes the immune response

It started with wine. Or more precisely, a conversation about it. "My colleagues and I were talking about how some people think drinking wine may be anti-inflammatory," recalls Xu Zhou, Ph.D., from the Division of Gastroenterology, ...

Recommended News For You

Prostate cancer death risk is higher in late teens and early 20s weight gain.

New study elucidates obesity's role in fueling breast cancer progression

Promising Results With Epcoritamab Monotherapy in Relapsed/Refractory CLL

Personalized Breast Cancer Treatment; Insights Into HPV in Men; Exercise and Cancer

Study reveals crucial gaps in oral cancer awareness in Middle East and North Africa

No Solace From Drug Scarcities; Novel Guidelines Regarding Lymphedema; A "Good" Patient Is Forgotten.

Antibody-drug conjugate shows promising safety and response rates for patients with rare blood cancer

Recommended Articles For You

Understanding Apoplexy: Symptoms, Causes, and Treatment Options  

The Pros and Cons of Using Cyclophosphamide in Cancer Treatment  

The Oncologist’s Edge: Tools, Trials, and Tech Transforming Treatment 

Unravelling the Mysteries of Monoclonal Gammopathy 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Many women undergo annual mammography, despite biennial screening recommendations

2.

Study Finds Actionable Mutations in Brain Mets of Breast Cancer Patients

3.

Some low-grade prostate cancers carry higher risks than biopsy suggests

4.

Why breast cancer survivors don't take their medicine, and what can be done about it.

5.

Novel Anti-CD38 Drug Shows Promise for Immune Thrombocytopenia

1.

The Danger of Rectus Sheath Hematoma: A Hidden Risk of Abdominal Surgery

2.

The Cutting-Edge of Phlebectomy: Redefining Vein Care

3.

Mastering Prostate Cancer Care: CME, Certification, Digital Tools, and Evidence-Based Strategies

4.

Unlocking the Mystery of Basilar Artery Stroke: A New Approach to Treatment

5.

Essential Oncology Tools: Risk Assessment, Telehealth, AI, and Monitoring

1.

International Lung Cancer Congress®

2.

Future NRG Oncology Meeting

3.

Genito-Urinary Oncology Summit 2026

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL

2.

First Line Combination Therapy- The Overall Survival Data in NSCLC Patients

3.

Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma

4.

Managing ALK+ NSCLC while Ensuring Long-Term Safety of the Patients

5.

Newer Immunotherapies for Myeloma- A Comprehensive Overview


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot